The table below shows CORCEPT THERAPEUTICS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$16.77M
$4.77M
$23.76M
$25.96M
$35.25M
$25.42M
Capital expenditure
$201.00K
$104.00K
$0.00
$0.00
$12.00K
$126.00K
Investing cash flow
$4.54M
-$3.17M
-$9.01M
$207.47M
-$50.50M
-$3.28M
Dividends paid
-
-
-
-
-
CORT operating cash flow (10-K history)
CORCEPT THERAPEUTICS INC reported operating cash flow of $142.00M for fiscal year 2025. That is down 28.4% from $198.29M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $18.39M (FY 2016) to $142.00M. Figures come from the company's audited annual reports as filed with the SEC.
